BioSpace News Archive

Genetown

Precede Biosciences to Present Scientific Data For Its Comprehensive Epigenomic Liquid Biopsy Platform at AACR 2024

Precede Biosciences announced three abstracts have been accepted for poster presentation at the American Association for Cancer Research Annual Meeting 2024 taking place April 5 – 10 in San Diego, California.

March 5, 2024
·
3 min read
Business

YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries

YS Biopharma Co., Ltd. today announced changes to its board of directors (the “Board”) and key strategic appointments within its wholly-owned subsidiaries in China.

March 5, 2024
·
2 min read
Genetown

ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices™ Cardiopulmonary Management (CPM) System

Analog Devices, Inc. (Nasdaq: ADI ) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the Sensinel ™ Cardiopulmonary Management (CPM) System.

March 5, 2024
·
7 min read
Deals

Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit

Akari Therapeutics, Plc and Peak Bio Inc. announce a definitive agreement to merge as equals in an all-stock transaction.

March 5, 2024
·
17 min read
Drug Development

Elysium Therapeutics Announces Compelling Human Proof-of-Concept Data for its SMART™ Opioid, O2P™ Hydrocodone Prodrug for Acute Pain that Could Disrupt the Industry by Establishing New Standards for Opioid Safety

Elysium Therapeutics today announced positive results from a Phase 1, human-proof-of-concept study (O2P-001) investigating the company’s proprietary Oral Overdose Protected (O2P™) hydrocodone prodrug for the treatment of moderate-to-severe acute pain.

March 5, 2024
·
7 min read
Edgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024

Edgewise Therapeutics, Inc. today announced that management will present at the Leerink Partners Global Biopharma Conference on Monday, March 11, 2024, at 12:00 pm ET.

March 5, 2024
·
1 min read
Bio NC

Carolina Partners with ChristianaCare Gene Editing Institute to Launch CRISPR in a Box™ Kits for High School Science Labs

Leading school science supplier Carolina Biological Supply Company announced an exclusive partnership with the ChristianaCare Gene Editing Institute to manufacture and distribute an affordable CRISPR in a Box™.

March 5, 2024
·
6 min read
Biotech Bay

Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care

Bone Health Technologies announced the company has raised a new $5 million funding round from leading investment firms, including Esplanade Ventures, Berkeley Catalyst Fund, as well as strategic investor and leading global medical technology provider Terumo Medical.

March 5, 2024
·
3 min read
Lone Star Bio

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

bioAffinity Technologies, Inc. reported accelerating growth of 375% in CyPath® Lung tests ordered and processed over the past three months as compared to the previous three months.

March 5, 2024
·
5 min read
Lone Star Bio

Lantern To Participate in H.C Wainwright & Co.’s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference

Lantern Pharma will present virtually on Thursday, March 7th at 2 pm Eastern.

March 5, 2024
·
6 min read